Compugen Ltd

Compugen Ltd

CGEN

Market Cap$155.23M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Compugen LtdCompugen Ltd-10.8--25%-0.2
$2.54

Current Fair Value

42.8% upside

Undervalued by 42.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$155.23 Million
Enterprise Value$153.05 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.16
Beta2.55
Outstanding Shares92,308,225

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.83
PEG915.38
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue5.55
Enterprise Value to EBIT-10.35
Enterprise Value to Net Income-11
Total Debt to Enterprise0.08
Debt to Equity0.22

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Compugen Ltd

CEO: Anat Cohen-Dayag

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immu...